Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Ulrich Bernd Keller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8485-1958; OpenAlex author ID A5028510513. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 7

  1. The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70794↗
  2. Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2025.08.018↗
  3. NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Co-author DOI 10.1073/pnas.2105691119↗
  4. The SUMO pathway in pancreatic cancer: insights and inhibition. Co-author DOI 10.1038/s41416-020-01119-6↗
  5. Rationale for MYC imaging and targeting in pancreatic cancer. Co-author DOI 10.1186/s13550-021-00843-1↗
  6. Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC. Co-author DOI 10.1002/1878-0261.12835↗
  7. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. Last author DOI 10.1136/gutjnl-2018-317856↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Günter Schneider · 7 shared papers, 2020–2026 · strength 1.06
  2. Matthias Wirth · 6 shared papers, 2020–2026 · strength 0.88
  3. Dieter Saur · 5 shared papers, 2020–2026 · strength 0.77
  4. Christian Schneeweis · 5 shared papers, 2020–2026 · strength 0.75
  5. Hazal Köse · 3 shared papers, 2022–2026 · strength 0.52
  6. Maximilian Reichert · 4 shared papers, 2020–2026 · strength 0.49
  7. Oliver Holger Krämer · 3 shared papers, 2020–2026 · strength 0.41
  8. Michael B. Ghadimi · 2 shared papers, 2026 · strength 0.40
  9. Constanza Tapia Contreras · 2 shared papers, 2026 · strength 0.40
  10. Elisabeth Heßmann · 2 shared papers, 2026 · strength 0.40
  11. Felix Orben · 3 shared papers, 2020–2026 · strength 0.39
  12. Roland Rad · 3 shared papers, 2020–2026 · strength 0.37
  13. Zonera Hassan · 3 shared papers, 2020–2021 · strength 0.35
  14. Josefina Doffo · 2 shared papers, 2020–2022 · strength 0.22
  15. Marian Grade · 1 shared paper, 2026 · strength 0.19
  16. Lukas Krauß · 1 shared paper, 2026 · strength 0.19
  17. Carolin Schneider · 1 shared paper, 2026 · strength 0.19
  18. Roland Michael Schmid · 1 shared paper, 2026 · strength 0.19
  19. Janine Murr · 1 shared paper, 2026 · strength 0.19
  20. Alexandra Nguyen · 1 shared paper, 2026 · strength 0.19
  21. Sebastian Mueller · 1 shared paper, 2026 · strength 0.19
  22. Volker Ellenrieder · 1 shared paper, 2026 · strength 0.19
  23. Elmar Wolf · 1 shared paper, 2022 · strength 0.12
  24. Iréne Esposito · 1 shared paper, 2022 · strength 0.12
  25. Katharina Lankes · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.